Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Apton Biosystems logo — Innovative optical system for superior sequencing and protei...

Apton Biosystems

Innovative optical system for superior sequencing and protein detection, enabling early disease detection and precision medicine advancements.

Founded 2012 11-50 employees Series A Total: $31.61M Biotechnology, Health Care

General Information

Company Name Apton Biosystems
Founded Year 2012
Employees 11-50
Industries Biotechnology, Health Care
Funding Stage Series A
Social

Get notified when Apton Biosystems moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Apton Biosystems

Apton Biosystems is a biotechnology startup founded in 2012, specializing in an innovative optical system for superior sequencing and protein detection. Their technology employs super-resolution to evaluate molecules positioned closer than a wavelength of light, enabling early disease detection and precision medicine advancements. This breakthrough has significant potential in biomarker discovery, early disease detection, and therapeutic monitoring, thereby enhancing preventive health and precision medicine. Apton Biosystems recently received a significant $24.60M Series A investment on 29 April 2021, with participation from esteemed investors including Casdin Capital, Khosla Ventures, and Kern Capital. This substantial investment underlines the confidence of these prominent investors in Apton Biosystems' potential to revolutionize the field of biotechnology and contribute to scientific and medical advancements.

Taxonomy: biomarker discovery, protein detection, optical system, super-resolution technology, early disease detection, therapeutic monitoring, precision medicine, preventive health, molecular evaluation, sequencing technology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 3
Investor Investor Investor
29 Apr 2021
Venture Round •••••• 1
Investor
12 Mar 2015

Apton Biosystems Alternatives & Competitors

Apton Biosystems vs
Wonsor
Wonsor

Specializing in automatic precision detection technology to deliver expert detection solutions and a...

Series Unknown
Manufacturing, Autonomous and Sensor Tech
Apton Biosystems vs
Hunan Runmei Gene Technology
Hunan Runmei Gene Technology China

Single-use samplers, RT-PCR method, antibody detection kit, virus extraction and detection kit

3 employees
Health Care, Manufacturing
Apton Biosystems vs
Zhongzhi Keyi
Zhongzhi Keyi

Pioneering advancements in photoelectric detection with specialized time-gated imaging and single-ph...

Series A
Manufacturing

FAQ About Apton Biosystems

Innovative optical system for superior sequencing and protein detection, enabling early disease detection and precision medicine advancements.
Apton Biosystems was founded in 2012.
Apton Biosystems operates in the following industries: Biotechnology, Health Care.
Apton Biosystems has approximately 11-50 employees.
Apton Biosystems has completed 2 funding rounds, raising a total of $31.61M. The latest funding stage is Series A.
Top alternatives and competitors to Apton Biosystems include Wonsor, Hunan Runmei Gene Technology, Zhongzhi Keyi, Detectors Group Inc., Huzhou Shenke. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Apton Biosystems and Wonsor are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Apton Biosystems and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy